Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069875 · ClinicalTrials.gov registry record · Phase 2
A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 195
- Enrollment target
NCT00069875: Completed Phase 2 study, sponsored by Eli Lilly and Company.
NCT00069875 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 195 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069875, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 195 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine and cisplatin in patients with non-small cell lung cancer.
Interventions
- DRUG Gemcitabine
- DRUG cisplatin
- DRUG LY293111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00069875 record still lists
NCT00069875 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 3 interventions - of which Gemcitabine is the first listed.
NCT00069875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069875 about?
NCT00069875 is a clinical study titled "A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer". The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine and cisplatin in patients with non-small cell lung cancer.
What is the current status of trial NCT00069875?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 195 participants. The study started on 2003-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00069875?
The interventions under investigation include: Gemcitabine (DRUG), cisplatin (DRUG), LY293111 (DRUG).
Who is sponsoring clinical trial NCT00069875?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00069875's enrollment target sits among peer trials
195 350th of 2000 higher than 1,649 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia